What is known on angiogenesis-related rare diseases? A systematic review of literature

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 12, 2012, Pages 2872-2893

  Rodríguez Caso, Luis ^a   Reyes Palomares, Armando ^a   Sánchez Jiménez, Francisca ^a,b   Quesada, Ana R ^a,b   Medina, Miguel Ángel ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Angiogenesis; Orphanet; Rare diseases

Indexed keywords

ANGIOGENESIS INHIBITOR;

ARTICLE; GENETICS; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RARE DISEASE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RARE DISEASES;

EID: 84871057804     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01616.x     Document Type: Article

References (24)

1. Ayme S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt-Gesund. 2007; 50: 1477-83.
2. Kaiser J. Human genetics. Affordable 'exomes' fill gaps in a catalog of rare diseases. Science. 2010; 330: 903.
3. Aymé S, Rath A, Bellet B. WHO international classification of diseases (ICD) revision process: incorporating rare diseases into the classification scheme: state of art. Orphanet J Rare Dis. 2010. doi:10.1186/1750-1172-5-S1-P1.
4. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 285: 1182-6.
5. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989; 246: 1306-9.
6. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003; 9: 653-60.
7. Quesada AR, Muñoz-Chápuli R, Medina MA. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev. 2006; 26: 483-530.
8. Medina MA, Muñoz-Chápuli R, Quesada AR. Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J Cell Mol Med. 2007; 11: 374-82.
9. Quesada AR, Medina MA, Alba E. Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. BioEssays. 2007; 29: 1159-68.
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70.
11. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009; 136: 823-37.
12. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438: 932-6.
13. Ferrara N. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med. 2010; 16: 1107-11.
14. Dispenzieri A. POEMS syndrome. Blood Rev. 2007; 21: 285-99.
15. Chee CE, Dispenzieri A, Gertz MA. Amyloidosis and POEMS syndrome. Expert Opin Pharmacother. 2010; 11: 1501-14.
16. Greenberg DA, Jin KL. From angiogenesis to neuropathology. Nature. 2005; 438: 954-9.
17. Reyes-Palomares A, Montañez R, Real-Chicharro A, et al. Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling. Bioinformatics. 2009; 25: 834-5.
18. Montañez R, Medina MA, Solé RV, et al. When metabolism meets topology: reconciling metabolite and reaction networks. BioEssays. 2010; 32: 246-56.
19. Ranea JAG, Morilla I, Lees JG, et al. Finding the "dark matter" in human and yeast protein network prediction and modelling. PLoS Comput Biol. 2010. doi:10.1371/journal.pcbi.1000945.
20. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009. doi:10.1371/journal.pmed.1000097.
21. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009. doi:10.1371/journal.pmed.1000100.
22. Renear AH, Palmer CL. Strategic reading, ontologies, and the future of scientific publishing. Science. 2009; 325: 828-32.
23. Hur J, Schuyler AD, States DJ, et al. SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics. 2009; 25: 838-40.
24. Blann AD, Ramcharan KS, Stonelake PS, et al. The angiome: a new concept in cancer biology. J Clin Pathol. 2011; 64: 637-43.